Why the study?
The role of statins in modulating the renin-angiotensin system pathway is an important but often neglected pleiotropic effect.
This review highlights the pleiotropic effects of statins on the renin-angiotensin system, suggesting potential new therapeutic applications in diseases like hypertension and heart failure.
Statins may block RAS components; leaves open whether this drives clinical benefits in hypertension or HF.
Statins, a class of drugs for lowering serum LDL-cholesterol, have attracted attention because of their wide range of pleiotropic effects. An important but often neglected effect of statins is their role in the renin-angiotensin system (RAS) pathway. This pathway plays an integral role in the progression of several diseases including hypertension, heart failure, and renal disease. In this paper, the role of statins in the blockade of different components of this pathway and the underlying mechanisms are reviewed and new therapeutic possibilities of statins are suggested.
No takes yet. Share an insight, caveat, or question.
Kiaie et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: